Search

Search Constraints

You searched for: Author/Creator Viglietta, Vissia

Search Results

1. [P1–053]: CHANGE FROM BASELINE IN CLINICAL DEMENTIA RATING SCALE COGNITIVE AND FUNCTIONAL DOMAINS IN PRIME, A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB (BIIB037). (1st July 2017)

2. Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience. Issue 2 (December 2015)

3. Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing–remitting multiple sclerosis: findings from the CONFIRM study. (February 2014)

4. Efficacy of delayed‐release dimethyl fumarate in relapsing‐remitting multiple sclerosis: integrated analysis of the phase 3 trials. (4th December 2014)

5. F2‐03‐04: ASSESSING CLINICAL MEANINGFULNESS OF OUTCOMES IN THE ALZHEIMER'S PREVENTION INITIATIVE GENERATION PROGRAM. (1st July 2019)

6. P1‐040: Clinical Dementia Rating‐Sum of Boxes Responder Analysis in Prime: A Randomized Phase 1B Study of the Anti‐Amyloid Beta Monoclonal Antibody Aducanumab (BIIB037). (1st July 2016)

10. The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease. Issue 1 (12th June 2019)